and diabetes mellitus [11] [12] [13] [14] [15] [16] . So this test can be used as a predictor of MS and its components. However there is currently no data in the literature regarding the relationship between thickness of EAT and KS disease. In this study, we aimed to assess the relationship between KS disease accepted as a component of MS and EAT thickness.
Materials and methods

Study population
Fifty-tree patients with KS disease and 39 healthy subjects were enrolled in our study. Patients were excluded if they had inadequate view on echocardiography, a history of any kind of cardiovascular disease, active infection and history of uric acid, cystin or struvite stones. For this reasons 8 KS patients were excluded because of cardiovascular disease in 4 and insuffi cient echocardiographic view in 4. Each participant signed an informed consent form in accordance with the Declaration of Helsinki, and this study was approved by the local ethical committee of Canakkale Onsekiz Mart University.
Measurements
Systolic and diastolic blood pressures were measured after 5 minutes of rest. Laboratory tests included fasting plasma glucose, creatinine, total cholesterol, High-Density Lipoprotein (HDL) cholesterol, Low Density Lipoprotein cholesterol (LDL), triglycerides. Biochemical measurements were made using standard biochemical techniques with a device from Beckman Coulter Ireland Inc., Mervue, Galway, Ireland. Body Mass Index (BMI) was calculated by dividing the weight in kilograms by the squared height in meters. MS diagnosed according to the National Cholesterol Education Program Adult Treatment Panel III [17] . MS was defi ned as the presence of 3 or more following components: systolic and diastolic blood pressure ≥130/85mmHg, fasting plasma glucose ≥110mg/dL, serum triglyceride ≥150mg/dL, HDL≥40mg/dL, and elevated waist circumference ≥102cm in men and ≥88cm in women.
The diagnosis of KS was established on the basis of the results of urinary ultrasound (Toshiba Aplio XG, Japan) using a 3.5MHz transducer. Renal calcifi cation was classifi ed as a urinary stone if the calcifi cation was located in the collecting system. Stone burden was also determined. All evaluations were performed by experienced radiologists, who did not have any information about metabolic status of the patients.
EAT measurements
Echocardiograms were performed with a Vivid 7 (Vingmed electronic,GE, Horten, Norway) instrument according to standard techniques. We measured EAT thickness on the free wall of right ventricle from the parasternal long-axis views. EAT was identifi ed as an echo-free space in the pericardial layers on the two-dimensional echocardiography, and its thickness was measured perpendicularly on the free wall of the right ventricle at end-diastole for 3 cardiac cycles [16, 18] ( Figure 1 ). An average value from these three measurements was obtained. The offl ine measurement of EAT thickness was performed by the same cardiologist who was unaware of the clinical data. 
Statistical analysis
Results
Forty-fi ve patients with KS disease and 39 healthy subjects were included in this study. Of the 84 patients included in the fi nal analysis, 44% were men and 56% were women.
Mean age was 50.52±10.4 years. Mean BMI was 25.5±3.4kg/ m2. Demographic and laboratory characteristics of the study population are presented in Table 1 . EAT thickness were higher (p<0.001) in KS disease patients than in healthy subjects ( Figure 2 ). Multivariable analysis showed that increased EAT thickness was associated with family history of urolithiasis.
EAT thickness was also signifi cantly correlated with triglyceride levels (r=0.627, p<0.001, Figure 3 ), LDL levels, age, and family history. Table 2 shows the correlation between EAT thickness and study parameters in patients.
Multiple linear regression analyses with stepwise method
were performed to evaluate independent variables of EAT thickness. Triglyceride levels, age, and family history of urolithiasis were independent predictors of EAT (Table 3 ).
Discussion
In our study EAT thickness were higher in KS disease than in control subjects and correlated with triglyceride levels, age and family history.
EAT is a component of visceral adiposity and related to MS and cardiovascular risk factors [11] [12] [13] 16] . Recently, there has been increased interest in EAT thickness as a marker of atherosclerosis. Inline with previous studies, it has been shown to be positively correlated with the severity of coronary artery disease [19] [20] [21] .
The MS seems to be a risk factor for stone formation, because all components of this syndrome have been demonstrated to be independent risk factor for urinary stone formation [1] [2] [3] [4] .
National Health and Nutrition Examination Survey III reported a signifi cant positive correlation between the MS traits and stone prevalence [22] . The association between MS and KS disease also confi rmed with imaging studies. In a large study in which 2132 Caucasian patients were reviewed, presence of MS was independently found related to ultrasonographic evidence of urolithiasis [23] . Although several studies have reported an association between urolithiasis and individual components of MS, none of them showed an clear evidence about this togetherness [4] [5] [6] [7] [8] [9] [10] . Rendina, et al., [5] , stated in their study that insulin resistance signifi cantly infl uences the urinary salts supersaturation, and KS formation results from a phase change in which urinary dissolved salts condense into solids, and all phase changes are driven by salts supersaturation [24] .
It has been shown in previous studies [6] [7] [8] [9] [10] , that, especially its components, not directly MS, may cause kidney stones, however, the underlying mechanisms have not clearly been demonstrated. In our study, we found the EAT thickness higher in KS disease than in control subjects. Furthermore positive family history of urolithiasis is a risk factor for increased EAT thickness, in KS disease patients. Therefore present study is the fi rst to report a clear evidence about relationship between MS and KS disease. There are several limitations in the present study. First, it is performed with a cross-sectional design. Second, urinary metabolic evaluations were not performed and urinary US was used as the main imaging modality instead of noncontrast computed tomography. However US has many advantages, including wide availability, low cost, and lack of radiation exposure. Finally, our study population is limited in numbers.
Therefore, these results should be confi rmed by large multicenter studies.
Conclusion
The relationship between KS disease and EAT thickness was researched in this study and EAT thickness was found to be higher in KS disease patients than in controls. We suggest that urolithiasis should be considered as a component of metabolic syndrome and EAT thickness may be useful to detect early atherosclerosis in urolithiasis.
